-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On February 16, Saiyuan Biotechnology (Hangzhou) Co.
Headquartered in Hangzhou, China, Saiyuan Bio focuses on the differentiation of engineered pluripotent stem cells (iPSCs) into innate immune cells (such as macrophages, natural killer cells, etc.
▲Saiyuan Bio’s pipeline under development (Image source: Saiyuan Bio’s official website)
According to the official website, Saiyuan Bio has established 6 R&D pipelines for hematological tumors and solid tumors, all of which are in the preclinical stage
(Original abridged)